✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Swedish Orphan Biovitrum AB (publ)

Common Name
Swedish Orphan Biovitrum
Country
Sweden
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,890
Ticker
SOBI
Exchange
NASDAQ STOCKHOLM AB
Description
Swedish Orphan Biovitrum AB is an international biopharmaceutical company headquartered in Stockholm, Sweden, specializing in treatments for rare diseases within haematology, immunology, and specialty...

Swedish Orphan Biovitrum's GHG Emissions Data Preview

In 2025, Swedish Orphan Biovitrum completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Swedish Orphan Biovitrum has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202520242023
2022 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Location-Based
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
Tracenable value for the metrica
Copy/Paste is a PRO feature.
Tracenable value for the metrica
0000000
Limited Data Preview
You are viewing a limited preview of Swedish Orphan Biovitrum’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2019, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=SOBI&reporting_period=2025"

Verified Sources Behind Swedish Orphan Biovitrum’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Swedish Orphan Biovitrum’s data sources below and access millions more through our Disclosure Search.

a. Swedish Orphan Biovitrum's Annual Report 2025
b. Swedish Orphan Biovitrum's Annual Report 2023
c. Swedish Orphan Biovitrum's Annual Report 2022

Insights into Swedish Orphan Biovitrum's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Swedish Orphan Biovitrum amounted to 1,575 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Swedish Orphan Biovitrum decreased by 19.19%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Swedish Orphan Biovitrum's Scope 1 Emissions Over Time

201920202021202220232024202503006009001.2 ktCO2e+21%+4%+12%+34%+4%-15%
  • Total Scope 1
  • Year-over-Year Change

What are Swedish Orphan Biovitrum's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Swedish Orphan Biovitrum were 932 metric tons of CO₂ equivalent (tCO₂e).a

Has Swedish Orphan Biovitrum reduced its Scope 1 emissions over time?

Since 2019, Swedish Orphan Biovitrum's Scope 1 emissions have increased by 66.43%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2024), Swedish Orphan Biovitrum's Scope 1 emissions decreased by 15.04%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Swedish Orphan Biovitrum's Scope 2 emissions?

In 2025, Swedish Orphan Biovitrum reported Scope 2 greenhouse gas (GHG) emissions of 533 tCO₂e using the market-based method and 643 tCO₂e using the location-based method.a

Has Swedish Orphan Biovitrum reduced its Scope 2 emissions over time?

Since 2019, Swedish Orphan Biovitrum's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 45.92%, reflecting a declining long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2024), Swedish Orphan Biovitrum's Scope 2 emissions (Location-Based) fell by 24.53% in 2025, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a

What methodology does Swedish Orphan Biovitrum use for Scope 2 reporting?

In 2025, Swedish Orphan Biovitrum reported its Scope 2 emissions using the market-based method and using the location-based method.a

Swedish Orphan Biovitrum's Scope 2 Emissions Over Time

201920202021202220232024202505501.1 k1.65 k2.2 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Swedish Orphan Biovitrum's Value Chain Emissions

In 2025, Swedish Orphan Biovitrum reported 302,303 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2025 disclosure of Swedish Orphan Biovitrum includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Swedish Orphan Biovitrum's Scope 3 Emissions Over Time

2022202320242025080 k160 k240 k320 ktCO2e+71%+31%+20%
  • Total Scope 3
  • Year-over-Year Change

What are Swedish Orphan Biovitrum's Scope 3 emissions?

In 2025, Swedish Orphan Biovitrum reported total Scope 3 emissions of 302,303 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a

Compared to the previous year (2024), Swedish Orphan Biovitrum's Scope 3 emissions increased by 19.85%, suggesting that the company faced challenges in reducing emissions across its value chain.a

What categories of Scope 3 emissions does Swedish Orphan Biovitrum disclose?

In 2025, Swedish Orphan Biovitrum reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Swedish Orphan Biovitrum's Scope 3 emissions?

In 2025, the largest contributors to Swedish Orphan Biovitrum's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 282,832 tCO₂e (93.56%)
  • Business Travel (Cat. 6): 8,499 tCO₂e (2.81%)
  • Capital Goods (Cat. 2): 4,940 tCO₂e (1.63%)

Swedish Orphan Biovitrum's Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(93.6%)Business Travel(Cat. 6)(2.8%)Capital Goods(Cat. 2)(1.6%)

Insights into Swedish Orphan Biovitrum’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Swedish Orphan Biovitrum reported Scope 1 greenhouse gas (GHG) emissions of 932 tCO₂e and total revenues of USD 3,070 millions. This translates into an emissions intensity of 0.3 tCO₂e per millions USD.a

Swedish Orphan Biovitrum's Scope 1 Emissions Intensity Compared to Peers

2050010,000200,0005,000,000Scope 1 Emissions (tCO2e)502005002,00010,000Revenues (Millions of USD)UCCAlkermesYear: 2023Scope 1: 14,763 tCO2eRevenue: $M 1,663Scope 1 Intensity: 8.88 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 930Scope 1 Intensity: 5.37 tCO2e/$MUUUnited LaboratoriesYear: 2024Scope 1: 1,528,572 tCO2eRevenue: $M 1,885Scope 1 Intensity: 810.79 tCO2e/$MAlmirallYear: 2025Scope 1: 5,339 tCO2eRevenue: $M 1,303Scope 1 Intensity: 4.10 tCO2e/$MBiogaiaYear: 2024Scope 1: 73 tCO2eRevenue: $M 129Scope 1 Intensity: 0.57 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MSawai Group HoldingsYear: 2023Scope 1: 19,500 tCO2eRevenue: $M 1,229Scope 1 Intensity: 15.87 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MSiegfried HoldingYear: 2025Scope 1: 52,000 tCO2eRevenue: $M 1,676Scope 1 Intensity: 31.03 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,680Scope 1 Intensity: 7.84 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2025Scope 1: 56,459 tCO2eRevenue: $M 2,642Scope 1 Intensity: 21.37 tCO2e/$MFagronYear: 2025Scope 1: 4,367 tCO2eRevenue: $M 1,119Scope 1 Intensity: 3.90 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MYuhanYear: 2024Scope 1: 7,059 tCO2eRevenue: $M 1,409Scope 1 Intensity: 5.01 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MGedeon RichterYear: 2024Scope 1: 45,632 tCO2eRevenue: $M 2,171Scope 1 Intensity: 21.02 tCO2e/$MCCChina TCMYear: 2024Scope 1: 104,425 tCO2eRevenue: $M 2,262Scope 1 Intensity: 46.16 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MIpsenYear: 2025Scope 1: 8,638 tCO2eRevenue: $M 4,619Scope 1 Intensity: 1.87 tCO2e/$MDr Reddy's LaboratoriesYear: 2025Scope 1: 142,772 tCO2eRevenue: $M 3,810Scope 1 Intensity: 37.47 tCO2e/$MSwedish Orphan BiovitrumYear: 2025Scope 1: 932 tCO2eRevenue: $M 3,070Scope 1 Intensity: 0.30 tCO2e/$M

How does Swedish Orphan Biovitrum's GHG emissions intensity compare to its peers?

In 2025, Swedish Orphan Biovitrum reported a Scope 1 emissions intensity of 0.3 tCO₂e per millions USD. Compared to the peer group median of 15.87, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Swedish Orphan Biovitrum rank on GHG emissions intensity within its industry?

In 2025, Swedish Orphan Biovitrum ranked 1 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Swedish Orphan Biovitrum among the top performers, with one of the lowest emissions intensities relative to peers.a

Insights into Swedish Orphan Biovitrum's Total Carbon Footprint

In 2025, Swedish Orphan Biovitrum reported a total carbon footprint of 303,878 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 19.56% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to Swedish Orphan Biovitrum's total carbon footprint was Scope 3 emissions, accounting for 99.48% of the company's total carbon footprint, followed by Scope 1 emissions at 0.31%.a

Want Full Access to Swedish Orphan Biovitrum's GHG Emissions Dataset?
Start 30-Day Free Trial